Cercar

12/10/2023 Periodic verification of results' comparability between several analyzers: Experience in the application of the EP31-A-IR guideline
Guiñón L., Illana F.J., Cuevas B., Canyelles M., Martínez-Bru C., García-Osuna Á.. Periodic verification of results' comparability between several analyzers: Experience in the application of the EP31-A-IR guideline. CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2023; 62(3)DOI:10.1515/cclm-2023-0994. PMID:37819627. IF:3.800(Q1/2D).
01/08/2023 Obesity-induced changes in cancer cells and their microenvironment: Mechanisms and therapeutic perspectives to manage dysregulated lipid metabolism
Lee-Rueckert, M, Canyelles, M, Tondo, M, Rotllan, N, Kovanen, PT, Llorente-Cortes, V, Escola-Gil, JC. Obesity-induced changes in cancer cells and their microenvironment: Mechanisms and therapeutic perspectives to manage dysregulated lipid metabolism. SEMINARS IN CANCER BIOLOGY. 2023; 93DOI:10.1016/j.semcancer.2023.05.002. PMID:37156344. IF:12.100(Q1/1D).
01/06/2023 "MiR-7 controls cholesterol biosynthesis through posttranscriptional regulation of DHCR24 expression"
Frutos, MFD, Pardo-Marques, V, Torrecilla-Parra, M, Rada, P, Perez-Garcia, A, Martin-Martin, Y, de la Pena, G, Gomez, A, Toledano-Zaragoza, A, Gomez-Coronado, D, Casarejos, MJ, Solis, JM, Rotllan, N, Pastor, O, Ledesma, MD, Valverde, AM, Busto, R, Ramirez, CM. "MiR-7 controls cholesterol biosynthesis through posttranscriptional regulation of DHCR24 expression". Biochimica et Biophysica Acta-Gene Regulatory Mechanisms. 2023; 1866(2)DOI:10.1016/j.bbagrm.2023.194938. PMID:37086967. IF:2.600(Q3/6D).
11/05/2023 Inhibitory Effects of LRP1-Based Immunotherapy on Cardiac Extracellular Matrix Biophysical Alterations Induced by Hypercholesterolemia
Samouillan, V, Garcia, E, Benitez-Amaro, A, Lhoest, MTLC, Dandurand, J, Dato, VA, Guerra, JM, Escola-Gil, JC, Chiabrando, G, Enrich, C, Llorente-Cortes, V. Inhibitory Effects of LRP1-Based Immunotherapy on Cardiac Extracellular Matrix Biophysical Alterations Induced by Hypercholesterolemia. JOURNAL OF MEDICINAL CHEMISTRY. 2023; 66(9)DOI:10.1021/acs.jmedchem.2c02103. PMID:37116069. IF:6.900(Q1/1D).
01/05/2023 Implantation of CPT1AM-expressing adipocytes reduces obesity and glucose intolerance in mice
Soler-Vazquez, MC, Romero, MD, Todorcevic, M, Delgado, K, Calatayud, C, Benitez-Amaro, A, Lhoest, MTL, Mera, P, Zagmutt, S, Bastias-Perez, M, Ibeas, K, Casals, N, Escola-Gil, JC, Llorente-Cortes, V, Consiglio, A, Serra, D, Herrero, L. Implantation of CPT1AM-expressing adipocytes reduces obesity and glucose intolerance in mice. METABOLIC ENGINEERING. 2023; 77DOI:10.1016/j.ymben.2023.04.010. PMID:37088334. IF:6.800(Q1/1D).
04/04/2023 SUCNR1 signaling in adipocytes controls energy metabolism by modulating circadian clock and leptin expression
Villanueva-Carmona, T, Cedo, L, Madeira, A, Ceperuelo-Mallafre, V, Rodriguez-Pena, MM, Nunez-Roa, C, Maymo-Masip, E, Repolles-de-Dalmau, M, Badia, J, Keiran, N, Mirasierra, M, Pimenta-Lopes, C, Sabadell-Basallote, J, Bosch, R, Caubet, L, Escola-Gil, JC, Fernandez-Real, JM, Vilarrasa, N, Ventura, F, Vallejo, M, Vendrell, J, Fernandez-Veledo, S. SUCNR1 signaling in adipocytes controls energy metabolism by modulating circadian clock and leptin expression. Cell Metabolism. 2023; 35(4)DOI:10.1016/j.cmet.2023.03.004. PMID:36977414. IF:27.700(Q1/1D).
01/01/2023 Remnant cholesterol: new outcomes highlight its potential as a clinically useful cardiovascular risk factor
Ferrer R., Mansilla A., Tondo M., Blanco-Vaca F.. Remnant cholesterol: new outcomes highlight its potential as a clinically useful cardiovascular risk factor. Journal Of Laboratory And Precision Medicine. 2023; 8DOI:10.21037/jlpm-22-70. PMID:. IF:(Q/D).
01/01/2022 MDA-LDL vaccination induces athero-protective germinal-center-derived antibody responses
Martos-Folgado I., del Monte-Monge A., Lorenzo C., Busse C.E., Delgado P., Mur S.M., Cobos-Figueroa L., Escolà-Gil J.C., Martín-Ventura J.L., Wardemann H., Ramiro A.R.. MDA-LDL vaccination induces athero-protective germinal-center-derived antibody responses. Cell Reports. 2022; 41(2)DOI:10.1016/j.celrep.2022.111468. PMID:36223741. IF:8.800(Q1/2D).